Red Mountain Compounding Pharmacy Recalls S-TRIMIX Injections for Sterility Concerns
First Royal Care Co. LLC is recalling S-TRIMIX compounded injections nationwide due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a risk of serious adverse health consequences such as infection.
Plain-English summary
First Royal Care Co. LLC, doing business as Red Mountain Compounding Pharmacy, is recalling S-TRIMIX compounded injections in various strengths. The recall is being conducted because of a lack of assurance of sterility in the product.
The affected products are prescription-only 5ml glass vials distributed nationwide in the United States. The recall covers multiple lot numbers and expiration dates, ranging from August 2019 to September 2019.
Consumers who have purchased or received these products should stop using them and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- S-TRIMIX various strengths to include:a) S-TRIMIX (15MG/1MG/10MCG/ML) MDV: b) S-TRIMIX (18MG/0.6MG/6MCG/ML) MDV INJ: c) S-TRIMIX (24MG/0.89MG/8.9MCG/ML) MDV INJ: d) S-TRIMIX (28.85MG/1.9MG/19.2MCG/ML) MDV: e) S-TRIMIX (30MG/1MG/10MCG/ML) MDV: f) S-TRIMIX (30MG/2MG/25MCG/ML)…
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #:a) S07162019DH@07
- EXP. 9/16/19 b) S06242019DH@01
- EXP 8/24/19
- S07102019DT@15
- EXP. 9/20/19
- S07252019DH@03
- EXP. 9/25/19
- S07312019DH@13
- EXP. 9/31/19 c) S07102019DT@03
- EXP. 9/10/19 d) S07262019DH@01
- EXP. 9/26/19
- S07232019DH@07
- EXP. 9/23/19 e) S06262019DH@05
- EXP. 8/26/19
- S07132019DT@06
- EXP. 9/13/19 f) S06162019DH@12
- EXP. 8/16/19 g) S06252019DT@06
- EXP. 8/25/19
- S07032019DT@04
- EXP. 9/3/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 100 recalled by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 100 products in this recall →Related recalls
Same manufacturer · First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
See all →- SevereMIT/B12 Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTestosterone Ultra 250MG/ML Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereRed Mountain Compounding Test Cypionate Sterility Assurance Recall
FDA (Drugs) · 2021-11-03
- SevereTEST CYP/PROP Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTEST CYP 25MG/ML Injectable Lacks Assurance of Sterility
FDA (Drugs) · 2021-11-03
Same hazard · sterility
See all →- SevereFDA Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-28
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFDA Recalls Key Pharmacy Compounded Sterile Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighMIC Compounded Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereKey Pharmacy Recalls TRI MIX Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Compounded Sterile Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereMIC/B12A Injectable Compounded Drug Recall for Sterility Assurance
FDA (Drugs) · 2021-11-03